Radionics XKnife System-Clinicians present latest advances in Brain and Spine tumor treatments





Integra LifeSciences Holdings Corporation announced today that Radionics(R) XKnife(R) clinicians presented their latest advances in the treatment of brain and spine tumors on Sunday, July 27th at the 50th annual meeting of the American Association of Physicists in Medicine in Houston, Texas. The Radionics(R) XKnife(R) radiosurgery system is developed, manufactured, and marketed by Integra LifeSciences Holdings Corporation, through its Integra NeuroSciences team.

 
Integra LifeSciences Holdings Corporation announced today that Radionics(R) XKnife(R) clinicians presented their latest advances in the treatment of brain and spine tumors on Sunday, July 27th at the 50th annual meeting of the American Association of Physicists in Medicine in Houston, Texas. The Radionics(R) XKnife(R) radiosurgery system is developed, manufactured, and marketed by Integra LifeSciences Holdings Corporation, through its Integra NeuroSciences team.

Dr. Satish Jaywant, Associate Professor of Radiation Oncology at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, presented his latest work using Radionics(R) XKnife(R) and ImageFusion(TM) software and cone beam CT to achieve stereotactic accuracy for extracranial targets.

Dr. Nilendu Gupta, Associate Professor and Chief of Clinical Medical Physics at James Cancer Center at the Ohio State Medical Center in Columbus, Ohio, presented his work in commissioning the XKnife(R) system for stereotactic spine treatments.

Emilie Soisson, medical physicist and assistant researcher at the University of Wisconsin Hospital and Clinics, presented her work on the Radionics(R) InterFix(TM) system for intracranial stereotactic positioning for use on the TomoTherapy(R) Hi – Art(R) system.

Jason D. Ellnor, Director of Marketing for stereotaxy at Integra NeuroSciences, It's exciting to see the advances our customers are making to treat tumors throughout the body utilizing the Radionics(R) XKnife(R) system as well as the Radionics(R) InterFix(TM) Radiosurgery Kit.

Unlike conventional surgery, XKnife(R) radiosurgery is completely noninvasive and does not require a surgical incision. This eliminates the discomfort and complications associated with standard surgery. Cancerous or other diseased tissue can be treated with focused radiation beams from a linear accelerator (linac) that are precisely guided using computer tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) images. Surrounding normal tissue is spared and patients are typically able to leave the hospital immediately after their treatment. To date, over 45,000 patients have undergone Radionics(R) XKnife(R) radiosurgery.

The Radionics(R) InterFix(TM) Radiosurgery Kit provides a way to adapt the existing Integra NeuroSciences stereotactic hardware to the TomoTherapy(R) Hi – Art(R) system for stereotactic treatment of cranial tumors and vascular malformations.

TomoTherapy Incorporated develops, manufactures and sells the TomoTherapy(R) Hi – Art(R) treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi . Art(R) treatment system combines integrated CT imaging with helical intensity modulated radiation therapy to deliver sophisticated treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. www.tomotherapy.com